SCOPUS 정보 검색 플랫폼

Volumn 6, Issue 12, 2000, Pages 4745-4754

Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis

(6) Ferrero Pous M a Hacene K a Bouchet, C a Le Doussal, V a Tubiana Hulin, M a Spyratos, F a

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOCHEMICAL MARKER; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR; PROTEIN P53; TAMOXIFEN; TUMOR MARKER; UROKINASE;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; DRUG EFFECT; DRUG RESPONSE; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ONCOGENE C ERB; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOASSAY; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TAMOXIFEN; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; URINARY PLASMINOGEN ACTIVATOR;

EID: 0034489891 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (74)

References (35)

1
- 0032078876
- ERBB2 oncogene in human breast cancer and its clinical significance
- (1998) Eur. J. Cancer , vol.34 , pp. 791-808
- Révillon, F.¹ Bonneterre, J.² Peyrat, J.P.³

2
- 0141542480
- Real-time transcription PCR assay for future management of ERBB2-based clinical applications
- (1999) Clin. Chem. , vol.45 , pp. 1148-1156
- Bièche, I.¹ Onody, P.² Laurendeau, I.³ Olivi, M.⁴ Vidaud, D.⁵ Lidereau, R.⁶ Vidaud, M.⁷

3
- 0031684721
- The HER-2/neu oncogene in breast cancer: Prognostic factor, predictive factor and target for therapy
- (1998) Oncologist , vol.3 , pp. 237-252
- Ross, J.S.¹ Fletcher, J.A.²

4
- 0027880138
- Prognostic factors and response to therapy in breast cancer
- (1993) Cancer Surv. , vol.18 , pp. 165-198
- Klijn, J.G.¹ Berns, E.M.² Foekens, J.A.³

5
- 70449185514
- Histological grading and prognosis in breast cancer
- (1957) Br. J. Cancer , vol.11 , pp. 359-377
- Bloom, H.J.¹ Richardson, W.W.²

6
- 0003419491
- Geneva: WHO
- (1968) Histological Typing of Breast Tumors
- Scarff, R.W.¹ Torloni, H.²

7
- 0019083094
- Breast cancer cooperative group. Revision of the standards for the assessment of hormone receptors in human breast cancer
- (1980) Eur. J. Cancer , vol.16 , pp. 1513-1515

8
- 0022531755
- Standardization of steroid receptor assays in human breast cancer. III. Selection of reference material for intra- and interlaboratory quality control
- (1986) Eur. J. Cancer Clin. Oncol. , vol.22 , pp. 939-944
- Thorpe, S.M.¹ Koenders, A.²

9
- 0029827297
- Improvement of quality control for steroid receptor measurements: Analysis of distributions in more than 40,000 primary breast cancers
- (1996) Breast Cancer Res. Treat. , vol.41 , pp. 131-140
- Romain, S.¹ Spyratos, F.² Goussard, J.³ Formento, J.L.⁴ Magdelenat, H.⁵

10
- 0025860662
- An antigen immunologically related to the external domain of gp185 is shed from nude mouse overexpressing the c-erbB-2 (HER-2/neu) oncogene
- (1991) Cancer Res. , vol.51 , pp. 2593-2598
- Langton, B.C.¹ Crenshaw, M.C.² Chao, L.A.³ Stuart, S.G.⁴ Akita, R.W.⁵ Jackson, J.E.⁶

11
- 0032938496
- Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: A multicentre study
- (1999) Br. J. Cancer , vol.80 , pp. 536-545
- Broët, P.¹ Spyratos, F.² Romain, S.³ Quillien, V.⁴ Daver, A.⁵ Ricolleau, G.⁶ Rallet, A.⁷ Toulas, C.⁸ Asselain, B.⁹

12
- 0027743354
- Clinical value of enzyme immunoassay of epidermal growth factor receptor in human breast cancer
- (1993) Breast Cancer Res. Treat. , vol.28 , pp. 215-221
- Iwase, H.¹ Kobayashi, S.² Itoh, Y.³ Kuzushima, T.⁴ Yamashita, H.⁵ Iwata, H.⁶ Naito, A.⁷ Yamashita, T.⁸ Itoh, K.⁹ Masaoka, A.¹⁰

13
- 0030057525
- Practical p-value adjustment for optimally selected cutpoints
- (1996) Stat. Med. , vol.5 , pp. 103-112
- Hilsenbeck, S.G.¹ Clark, G.M.²

14
- 33845382806
- Nonparametric estimation from incomplete observations
- (1958) J. Am. Stat. Assoc. , vol.53 , pp. 457-481
- Kaplan, E.L.¹ Meier, P.²

15
- 0017365573
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
- (1977) Br. J. Cancer , vol.35 , pp. 1-39
- Peto, R.¹ Pike, M.C.²

16
- 0000336139
- Regression models and life tables
- (1972) J. R. Stat. Soc. , vol.34 , pp. 187-220
- Cox, D.R.¹

17
- 0028232729
- Sensitivity of HER-2/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression
- (1994) Cancer Res. , vol.54 , pp. 2771-2777
- Press, M.F.¹ Hung, G.² Godolphin, W.³ Slamon, D.J.⁴

18
- 0029742067
- Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer
- (1996) Cancer Res. , vol.56 , pp. 3823-3830
- Robertson, K.W.¹ Reeves, J.R.² Smith, G.³ Keith, N.⁴ Ozanne, B.W.⁵ Cooke, T.G.⁶ Stanton, P.D.⁷

19
- 0032033686
- Quantitative determination of c-erbB-2 in human breast tumours: Potential prognostic significance of low values
- (1998) Eur. J. Cancer , vol.34 , pp. 476-481
- Koscielny, S.¹ Terrier, P.² Daver, A.³ Wafflart, J.⁴ Goussard, J.⁵ Ricolleau, G.⁶ Delvincourt, C.⁷ Delarue, J.C.⁸

20
- 85086348075
- Response - More about: Prognostic importance of low c-erbB2 expression in breast tumors
- (2000) J. Natl. Cancer Inst. , vol.92 , pp. 1443-1444
- Spyratos, F.¹ Ferrero-Poüs, M.² Tubiana-Hulin, M.³ Hacene, K.⁴

21
- 0028301750
- Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy
- (1994) Cancer (Phila.) , vol.73 , pp. 2359-2365
- Têtu, B.¹ Brisson, J.²

22
- 0025781290
- Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors
- (1991) Int. J. Cancer , vol.49 , pp. 44-49
- Rilke, F.¹ Colnaghi, M.I.² Cascinelli, N.³ Andreola, S.⁴ Baldini, M.T.⁵ Bufalino, R.⁶ Della Porta, G.⁷ Menard, S.⁸ Pierroti, M.A.⁹ Testori, A.¹⁰

23
- 0030591580
- No additive impact on patient survival of the double alteration p-53 and c-erbB-2 in breast carcinoma
- (1996) J. Natl. Cancer Inst. , vol.17 , pp. 1002-1003
- Menard, S.¹ Casalini, P.² Pilotti, S.³ Cascinelli, N.⁴ Rilke, F.⁵ Colnaghi, M.I.⁶

24
- 0030029626
- p53 protein as a prognostic indicator in breast carcinoma: A comparison of four antibodies for immunohistochemistry
- (1996) Br. J. Cancer , vol.73 , pp. 29-35
- Horne, G.M.¹ Anderson, J.J.² Tiniakos, D.G.³ McIntosh, G.G.⁴ Thomas, M.D.⁵ Angus, B.⁶ Henry, J.A.⁷ Lennard, T.W.⁸ Horne, C.H.⁹

25
- 0344333420
- Prognostic value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers
- (1998) J. Clin. Oncol. , vol.16 , pp. 462-469
- Sjörgen, S.¹ Inganäs, M.² Lindgren, A.³ Holmberg, L.⁴ Bergh, J.⁵

26
- 0028360192
- ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer
- (1994) Cancer Lett. , vol.81 , pp. 137-144
- Borg, A.¹ Baldetorp, B.² Fernö, M.³ Killander, D.⁴ Olsson, H.⁵ Rydén, S.⁶ Sigurdsson, H.⁷

27
- 0029662337
- c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases
- (1996) J. Clin. Oncol. , vol.14 , pp. 2702-2708
- Carlomagno, C.¹ Perrone, F.² Gallo, C.³ De Laurentiis, M.⁴ Lauria, R.⁵ Morabito, A.⁶ Pettinato, G.⁷ Panico, L.⁸ D'Antonio, A.⁹ Bianco, R.¹⁰ De Placido, S.¹¹

28
- 10144258654
- Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer
- (1996) J. Clin. Oncol. , vol.14 , pp. 2843-2877

29
- 0026502860
- Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer
- (1992) Br. J. Cancer , vol.65 , pp. 118-121
- Wright, C.¹ Nicholson, S.² Angus, B.³ Sainsbury, J.R.C.⁴ Farndon, J.⁵ Cairns, J.⁶ Harris, A.L.⁷ Horne, C.H.⁸

30
- 0031930148
- HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: A Southwest Oncology Group Study
- (1998) Clin. Cancer Res. , vol.4 , pp. 7-12
- Elledge, R.M.¹ Green, S.² Ciocca, D.³ Pugh, R.⁴ Allred, D.C.⁵ Clark, G.M.⁶ Hill, J.⁷ Ravdin, P.⁸ O'Sullivan, J.⁹ Martino, S.¹⁰ Osborne, C.K.¹¹

31
- 0026576399
- HER-2/neu in node-negative breast cancer: Prognostic significance of overexpression influenced by the presence of in situ carcinoma
- (1992) J. Clin. Oncol. , vol.10 , pp. 599-605
- Allred, D.C.¹ Clark, G.M.² Tandon, A.K.³ Molina, R.⁴ Tormey, D.C.⁵ Osborne, C.K.⁶ Gilchrist, K.W.⁷ Mansour, E.G.⁸ Abeloff, M.⁹ Eudey, L.¹⁰ McGuire, W.L.¹¹

32
- 0029591205
- c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer
- (1995) Eur. J. Cancer , vol.31 A , pp. 2185-2190
- Stål, O.¹ Sullivan, S.² Wingren, S.³ Skoog, L.⁴ Rutqvist, L.E.⁵ Carstensen, J.M.⁶ Nordenskjöld, B.⁷

33
- 0028354305
- c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer
- (1994) N. Engl. J. Med. , vol.330 , pp. 1260-1266
- Muss, H.B.¹ Thor, A.D.² Berry, D.A.³ Kute, T.⁴ Liu, E.T.⁵ Koerner, F.⁶ Cirrincione, C.T.⁷ Budman, D.R.⁸ Wood, W.C.⁹ Barcos, M.¹⁰ Henderson, I.C.¹¹

34
- 0032538050
- erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer
- (1998) J. Natl. Cancer Inst. , vol.90 , pp. 1346-1360
- Thor, A.D.¹ Berry, D.A.² Budman, D.R.³ Muss, H.B.⁴ Kute, T.⁵ Henderson, I.C.⁶ Barcos, M.⁷ Cirrincione, C.⁸ Edgerton, S.⁹ Allred, C.¹⁰ Norton, L.¹¹ Liu, E.T.¹²

35
- 0032538040
- erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer
- (1998) J. Natl. Cancer Inst. , vol.90 , pp. 1361-1370
- Paik, S.¹ Bryant, J.² Park, C.³ Fisher, B.⁴ Tan-Chiu, E.⁵ Hyams, D.⁶ Fisher, E.R.⁷ Lippman, M.E.⁸ Wickerham, D.L.⁹ Wolmark, N.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.